Latigo Biotherapeutics LTGO
$13.00 −$0.24 (-1.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.00 0.00%
Open$13.22
Prev close$13.24
Day range$11.91 – $13.35
Volume267.2K
Market cap$861.89M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts3
Average target$57.67+343.6% vs. price
- Buy 100%
Low $50.00Now $13.00Avg $57.67High $73.00
Recent rating changes
The last 4 actions on file set price targets from $50.00 to $73.00, averaging $55.75.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Nov 2026 | Guggenheim | BUY | $50.00 |
| 1 Sep 2026 | Jefferies | BUY | $50.00 |
| 1 Sep 2026 | Goldman Sachs | BUY | $73.00 |
| 1 Sep 2026 | Guggenheim | BUY | $50.00 |
No comments yet — be the first to weigh in on LTGO.
Sign in to join the discussion.